These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2220670)

  • 41. A retrospective study of positive antibody screens at delivery in Rh-negative parturients.
    Cambic CR; Scavone BM; McCarthy RJ; Eisenberg P; Sanchez EM; Sullivan JT; Wong CA
    Can J Anaesth; 2010 Sep; 57(9):811-6. PubMed ID: 20661682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Tube, Gel, and Immunochromatographic Strip Methods for Evaluation of Blood Transfusion Compatibility in Horses.
    Luethy D; Owens SD; Stefanovski D; Nolen-Walston R; Giger U
    J Vet Intern Med; 2016 Nov; 30(6):1864-1871. PubMed ID: 27770509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased efficiency of transfusion practice in routine surgery using pre-operative antibody screening and selective ordering with an abbreviated crossmatch.
    Dodsworth H; Dudley HA
    Br J Surg; 1985 Feb; 72(2):102-4. PubMed ID: 3971112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical Solutions for Problems in Blood Grouping and Crossmatching.
    Andıç N
    Turk J Haematol; 2022 Feb; 39(1):55-60. PubMed ID: 34886658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing.
    Mei Z; Wool GD
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):797-811. PubMed ID: 31466605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing.
    Pandey P; Setya D; Srivastava R; Singh MK
    Immunohematology; 2020 Jan; 36(1):19-28. PubMed ID: 32324041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 49. The new look in pretransfusion compatibility testing.
    Schmidt PJ
    Pathologist; 1985 Jul; 39(7):31-3. PubMed ID: 10272024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Containing costs in the blood bank by reducing unnecessary crossmatching.
    Friedman BA
    Pathologist; 1984 Jul; 38(7):405-10. PubMed ID: 10267505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type and screen system for elective surgery in obstetrics and gynecology.
    Nakamura Y; Takano A; Shinagawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):141-4. PubMed ID: 3973432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities.
    Wrenn SM; Marroquin CE; Hain DS; Harm SK; Pineda JA; Hammond PB; Shah DH; Hillyard SE; Fung MK
    Hum Immunol; 2018 Aug; 79(8):602-609. PubMed ID: 29864460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM; Summers TC; Sinor LT; Plapp FV
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reducing blood utilization by implementation of a type-and-screen transfusion policy a single-institution experience.
    Alghamdi S; Gonzalez B; Howard L; Zeichner S; LaPietra A; Rosen G; Garcia G; Lamelas J; Goldszer R
    Am J Clin Pathol; 2014 Jun; 141(6):892-5. PubMed ID: 24838335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [3 new antibody detection tests. A comparative study].
    Mempel W; Alraun K; Leeping M; Kirschner M; Reiser H; Heim MU
    Beitr Infusionsther; 1990; 26():362-6. PubMed ID: 1703872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
    Chaudhary R; Agarwal N
    Asian J Transfus Sci; 2011 Jul; 5(2):157-9. PubMed ID: 21897596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population.
    Roback JD; Barclay S; Moulds JM; Denomme GA
    Transfusion; 2015 Jun; 55(6 Pt 2):1522-8. PubMed ID: 25753019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfusion Blood Bank (Recipient) Testing.
    Alquist CR; Helander L
    Clin Lab Med; 2021 Dec; 41(4):599-610. PubMed ID: 34689967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfusion Preparedness Strategies for Obstetric Hemorrhage: A Cost-Effectiveness Analysis.
    Einerson BD; Stehlikova Z; Nelson RE; Bellows BK; Kawamoto K; Clark EAS
    Obstet Gynecol; 2017 Dec; 130(6):1347-1355. PubMed ID: 29112646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.